최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한한방내과학회지 = The journal of internal Korean medicine, v.37 no.3, 2016년, pp.442 - 452
이지원 (동신대학교 한의과대학 내과학교실) , 최창원 (동신대학교 한의과대학 내과학교실) , 전상윤 (동신대학교 한의과대학 내과학교실) , 한창우 (부산대학교한방병원 내과학교실) , 하예진 (원광대학교 한의과대학 내과학교실)
Objectives: This study was performed to investigate the anti-lipogenic effect and the mechanism of Jungmanbunso-hwan extract (JMBSH) on a cellular model of non-alcoholic fatty liver disease (NAFLD) caused by palmitate in HepG2 cells.Methods: The JMBSH was prepared, andHepG2 cells were treated with v...
Sourianarayanane A, Pagadala MR, Kirwan JP. Management of non-alcoholic fatty liver disease. Minerva Gastroenterol Dietol 2013;59(1):69-87.
Masuoka HC, Chalasani N. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann N Y Acad Sci 2013; 1281:106-22.
Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94(9):2467-74.
Jun DW. Influence of dietary intake on non-alcoholic fatty liver disease in Korean. National Institute of Food and Drug Safety Evaluation 2012;1-188.
Beaton MD. Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Can J Gastroenterol 2012;26(6):353-7.
Shyangdan D, Clar C, Ghouri N, Henderson R, Gurung T, Preiss D, et al. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technol Assess 2011; 15(38):1-110.
Professors of Department of Internal Medicine of liver system, National College of Korean Medicine. Gangye Naegwahak. Seoul: Nado; 2013, p. 102-15, 321-8.
Lee G. Nansilbijang. Seoul: Euiseongdang; 1994, p. 15.
Lee C. Euhak Ibmun. Seoul: Beop In publishing company; 2009, p. 1808.
Joo JH. Dangyesimbeop Buyeo(new edition). Seoul: Dae Seong publishing company; 1993, p. 298.
Woo D. Euhak Jeongjeon. Seoul: Seongbosa; 1986, p. 143-4.
Jin JP. Manbyeong Hoichun(paginal translation). Seoul: Beop In publishing company; 2007, p. 391-2.
Heo J. Dongui Bogam(paginal translation). Hadong: Dongui Bogam publishing company; 2010, p. 1434.
Wang A. Uibang Jiphae. Seoul: Dae Seong publishing company; 1992, p. 398-400.
Lee YU, Kim HC, Kim JS. The effect of Chungmanbunso-whoan on mouse hepatocyte damages induced by paraquat. Journal of Korean Medicine 1999;20(3):18-26.
Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108(8):1167-74.
Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 2000;6(9):998-1003.
Choi WC. Nonalcoholic Fatty Liver disease. Inje Medical J 2002;23(2):217-24.
Amgulo, P. Nonalcoholic fatty liver dusease. New England journal Med 2002;346:1221-31.
Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-45.
Park SH. Nonalcoholic steatohepatitis: Pathogenesis and treatment. Korean J Hepatol 2008;14(1): 12-27.
Han CW, Joo MS, Lee JH. Comparison of the Therapeutic Efficacy of Rhizoma Alismatis, Fructus Crataegi, Fructus Lycii, Radix Curcumae, Radix Salviae Miltiorrhizae, Herba Artemisiae Scopariae on the Experimental Cellular Model of Nonalcoholic Fatty Liver Disease. Korean J Orient Int Med 2012;33(4):533-42.
Jang YS, Seo JY, Kwun MJ, Kwon JN, Lee I, Hong JW, et al. Effect of Phaseolus angularis Seed on Experimental Cellular Model of Nonalcoholic Fatty Liver Disease. Korean J Oriental Physiology & Pathology 2013;27(6):802-8.
Choi JY, Kim SY, Kwun MJ, Kim KH, Joo MS, Han CW. Effects of Ethanol Extract of Benincasa Seeds on the Experimental Cellular Model of Nonalcoholic Fatty Liver Disease. Korean J Orient Int Med 2012;33(4):438-47.
Kim SY, Kwon JN, Lee I, Hong JW, Choi JY, Park SH, et al. Research on Anti-lipogenic Effect and Underlying Mechanism of Laminaria japonica on Experimental Cellular Model of Non-alcoholic Fatty Liver Disease. Korean J Orient Int Med 2014;35(2):175-83.
Choi MY, Woo HJ, Kim YC, Lee JH. Effects of Gamisaenggan-tang on high fat diet induced nonalcoholic fatty liver disease. Korean J Orient Int Med 2009;30(2):365-74.
Shin SS, Yoon MC, Tsung PC, Lee YT. Gambigyeongsinhwan(1) Improves Body Weight and Lipid Metabolism in High Fat Diet-Fed Obese Animal Model. Kor J Herbology 2014; 29(1):35-43.
Roh JS, Lee HR, Ahn YJ, Yoon MC, Shin SS. Massa Medicata Fermentata improves fatty liver in high fat diet-fed nonalcoholic fatty liver disease’s mouse model. Kor J Herbology 2014;29(2):23-31.
Department of Internal Medicine of kidney system, National College of Korean Medicine. Syngye Naegwahak. Seoul: Gunja publishing company; 2011, p. 89-96.
Gwon GH. Huang Di Nei Jing (Editing). Seoul: Banryong; 2005, p. 21, 77, 120, 367.
Jo HG, Kim BT. The Bibliographical Study on Causes, Mechanisms and the Chief Virtues on Obesity, Collected papers of Institute of Oriental medicine 1992;1(2):61-71.
Bang HJ, Tak US, Hong YH, Gang YH. Korean medical consideration of hyperlipidemia. The J of East-West medicines 1995;20(1):25-36.
Kola B, Grossman AB, Korbonits M. The role of AMP-activated protein kinase in obesity. Front Horm Res 2008;36:198-211.
Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 1999; 277(1 Pt 1):E1-10.
Park H, Kaushik VK, Constant S, Prentki M, Przybytkowski E, Ruderman NB, et al. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMPK in rat tissues in response to exercise. J Biol Chem 2002;277(36):32571-7.
Kawaguchi T, Osatomi K, Yamashita H, Kabashima T, Uyeda K. Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J Biol Chem 2002;277(6):3829-35.
Muoio DM, Seefeld K, Witters LA, Coleman RA. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 1999;338(Pt3):783-91.
Clarke PR, Hardie DG. Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. EMBO J 1990;9(8):2439-46.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.